Vistagen Therapeutics, Inc. VTGN Q1 2026 Annual earnings

FAQ

When did Vistagen Therapeutics, Inc. report Q1 2026 earnings?

Vistagen Therapeutics, Inc. (VTGN) reported Q1 2026 earnings on June 15, 2026 before market open.

What were Vistagen Therapeutics, Inc.'s Q1 2026 revenue and EPS?

Vistagen Therapeutics, Inc. reported revenue of $464.0K and eps of $-0.37 for Q1 2026.

Did Vistagen Therapeutics, Inc. beat estimates in Q1 2026?

Revenue beat the consensus estimate of $399.9K by $64.1K. EPS missed the consensus estimate of $-0.34 by $0.03.

How did Vistagen Therapeutics, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 3193.3% from -$15.0K a year earlier and eps grew 14.0% from $-0.43.

Where can I find Vistagen Therapeutics, Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001628280-26-043232) and the 10-K periodic report (0001628280-26-043271) directly on SEC EDGAR. The filing index links above go to sec.gov.